EGFR and cholangiocarcinoma: To elucidate the biological significance and potential of these molecules as therapeutic targets, we investigated EGFR/VEGF/HER2 expression and attempted to elucidate their associations with various clinical features as well as patient survival in 236 cases of cholangiocarcinomas.